Nih
Nih funding pages collect matching grants, scholarships, benefits, fellowships, and other programs from the FindMyMoney.App directory. Use this page to compare current opportunities, then verify deadlines and eligibility on the official source before applying.
RFA-HL-26-016: Catalyze Enabling Technologies and Transformative Platforms for HLBS Research (R33)
NIH's NHLBI Catalyze R33 opportunity funds enabling technologies and transformative platforms in heart, lung, blood, and sleep (HLBS) research with strong validation milestones and measurable performance measures.
RFA-HL-26-017: NIH Catalyze Product Definition for Small Molecules and Biologics (R61/R33)
NIH's RFA-HL-26-017 supports early-stage translational projects that generate and validate therapeutic candidates for HLBS diseases through a phased R61/R33 development pathway.
RFA-HL-26-019: Catalyze Product Definition - Medical Device Prototype Design/Testing, Diagnostics, and Assay Development (R61/R33)
NIH NHLBI Catalyze Product Definition NOFO for phased R61/R33 support of early-stage device, diagnostic, and assay development (clinical trials not allowed), with ongoing application rounds in 2026 and 2027.
RFA-HL-26-020: Catalyze: Product Definition Medical Device Prototype Optimization (R33)
NHLBI Catalyze RFA-HL-26-020 funds late-stage prototype optimization for medical devices, diagnostics, and research tools for heart, lung, blood, and sleep disorders via R33 awards.
RFA-HL-27-004: Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
NIH’s NHLBI RFA-HL-27-004 is a limited-competition R03 small grant opportunity to help current and recently completed NHLBI K01/K08/K23/K25 awardees advance toward independent funding through a short, NIH-funded pilot- to proof-of-concept scale project.
RFA-MH-26-120: BRAIN Initiative Reagent Resources for Brain Cell Type-Specific Access (U24)
NIH’s BRAIN Initiative cooperative agreement funds facilities that produce and distribute brain cell type-specific access and manipulation reagents for neuroscience users.
RFA-MH-26-140: BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional)
NIH BRAIN Initiative NOFO for a U01 cooperative agreement to develop next-generation sensors and bioelectronic devices that capture synchronized behavioral and neural data in naturalistic contexts, with a reported $10 million estimate for 6-8 awards at each receipt date.
RFA-MH-26-170: BRAIN Initiative - Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01)
NIH BRAIN Initiative reissue NOFO for R01 projects that develop and validate high-impact tools for precise, cell- and circuit-specific neuroscience research without clinical trials.
RFA-MH-27-135: Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (R01 Clinical Trials Required)
NIH/NIMH is seeking R01 research grants focused on rigorous clinical trials and trial methods for rapid-acting psychotropic interventional drug development, with a FY2027 budget totaling about $5.5M.
RFA-MH-27-180: Advancing Research on Empirically-Supported Interventions for Older Adults Living with Serious Mental Illness (R01 Clinical Trial Optional)
NIH NIMH is seeking R01 projects that adapt, optimize, and scale evidence-based interventions for adults 50+ living with serious mental illness, with initial submission opening in Sept 2026 and due Oct 15, 2026.